European Journal of Endocrinology · 2013 · 22 citations · 10 references
MedicineOncologyOrthopedic SurgeryBone MetabolismOrthopaedic OncologyOrthopedic OncologyBone DisordersBone Metabolism DisordersBone PathologyBone TissueBone TumorsMetabolic Bone DiseaseAbnormal Bone MineralizationBone Mineral DensityBone Mineral Density DeclineLytic Bone LesionsOsteolytic Bone DiseaseOsteolytic Bone LesionsSclerotic Bone LesionsTumor-induced Osteomalacia
OBJECTIVE: Tumor-induced osteomalacia is a rare paraneoplastic syndrome characterized by hypophosphatemia and inappropriately normal or low 1,25-dihydroxyvitamin D. CLINICAL CASE: Here, we report a 6-year postoperative follow-up of a patient with oncogenic osteomalacia with a distinctive skeletal manifestation. The latter was characterized by an almost linear lytic lesion of a few millimeters with irregular borders, mainly involving the trabecular compartment but extending into cortical shell, located in the middle third of the right fibula. Six years after tumor resection, a sclerotic repair with a complete recovery was observed. Furthermore, we monitored a striking increase in bone mineral density throughout the observation period, reaching a peak of 73% over basal values at lumbar spine after 2 years; at total femur and radius, the peak was 47.5 and 4.6% respectively, after 4 years from tumor resection. CONCLUSIONS: We report for the first time that an osteolytic lesion may be part of the skeletal involvement in tumor-induced osteomalacia.
10
Suzanne M. Jan de Beur · JAMA · 2005 · 251 citations
Medicine, Nephrology, Oncology +17
Cristiana Cipriani, Elisabetta Romagnoli, Alfredo Scillitani et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 92 citations · Full text
Medicine, Endocrinology, Nutrition +17